Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
Published on: October 4, 2024
Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases
Shikun Yang1, Aimei Li1, JianWen Wang1
1Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Background:
Kidney disease is a serious problem that adversely affects human health, but critical knowledge is lacking on how to effectively treat established chronic kidney disease. Mounting evidence from animal and clinical studies has suggested that Vitamin D Receptor (VDR) activation has beneficial effects on various renal diseases.
Methods:
A structured search of published research literature regarding VDR structure and function, VDR in various renal diseases (e.g., IgA nephropathy, idiopathic nephrotic syndrome, renal cell carcinoma, diabetic nephropathy, lupus nephritis) and therapies targeting VDR was performed for several databases.
Result:
Included in this study are the results from 177 published research articles. Evidence from these papers indicates that VDR activation is involved in the protection against renal injury in kidney diseases by a variety of mechanisms, including suppression of RAS activation, anti-inflammation, inhibiting renal fibrogenesis, restoring mitochondrial function, suppression of autoimmunity and renal cell apoptosis.
Conclusion:
VDR offers an attractive druggable target for renal diseases. Increasing our understanding of VDR in the kidney is a fertile area of research and may provide effective weapons in the fight against kidney diseases.
Insights
Vitamin D Receptor (VDR) activation shows promise for treating kidney diseases. Research indicates VDR plays a protective role against renal injury through multiple mechanisms, offering a potential therapeutic target.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Background:
- Chronic kidney disease (CKD) poses a significant health burden with limited treatment options.
- Emerging evidence suggests Vitamin D Receptor (VDR) activation benefits various renal conditions.
Purpose of the Study:
- To review the role of VDR in kidney diseases.
- To explore VDR-targeting therapies for renal conditions.
Main Methods:
- A systematic literature search was conducted across multiple databases.
- The search focused on VDR structure, function, its involvement in specific kidney diseases, and VDR-targeted therapies.
Main Results:
- VDR activation protects against renal injury via mechanisms like suppressing the renin-angiotensin system (RAS), reducing inflammation, and inhibiting fibrosis.
- Additional benefits include restoring mitochondrial function, suppressing autoimmunity, and preventing renal cell apoptosis.
Conclusions:
- Vitamin D Receptor (VDR) presents a viable therapeutic target for kidney diseases.
- Further research into VDR's function in the kidney could lead to effective treatments for renal diseases.
More Related Videos
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
10:51A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Vitamins
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Kidney Structure